Chris Villavarayan
Analyst · BMO Capital Markets.
Yes, that's a great question. I mean, I think if you look at our Q2, we had good performance in the quarter, which was just unfavorably impacted by our ERP launches that was primarily around 1 plant. And if you take that out, our guidance puts us on record earnings levels despite our investments in enterprise programs and obviously some elevated compensation spend comparing this year to last year. And if you talk about all those positive catalysts, price-mix, as we talk about this quarter is up 7%. Price-cost improvements continues to track well. And again, we do see as we head into Q3 and Q4, pricing will be a little bit more muted. As we started the year, we had about $120 million of cume price-cost gap across two of our businesses, about 60% of that resolved across the Mobility and Industrial business, and we expect to have that solved through the year. And then talking about additional positive catalyst, specialty raws. With the exception of specialty raws like TiO2, the raw material benefit, as Sean talked about, continues to track well for the second half and we do see that being a positive tailwind into Q4. And so when you take all that, and I think if you take a look at our Q4 guide, to what we built, even with the guide we had without the upside of solving the backlog in the Refinish side, it puts us at a midpoint at 243. And at the high point, what you will get is the second best quarter in the history -- the 10-year history of Axalta in terms of a Q4 performance. Usually, we see Q4 coming down. And if you take the top end of that guide, it essentially puts you as the best performance Axalta has seen, with the exception of 2020 where we've obviously had to take some actions to get there. So it just talks to the underlying performance that exists in the company, obviously, once we get past these operational issues that I do believe we will have more than solved over the next two quarters.